Year: 2024
Type: article
Abstract: Basal cell carcinoma is the most common malignant tumor in the fair-skinned population and its incidence continues to rise. An update of the S2k guideline with the participation of all specialist societies familiar with the clinical picture and previous literature research is of great importance for the quality of care for affected patients. In addition to epidemiology, diagnostics and histology are discussed. After risk stratification, therapy is divided into topical, systemic and radiation therapy. Surgical removal remains the treatment of first choice in most cases. The approval of anti-PD1 inhibitors for locally advanced and metastatic tumors has opened up a new option in second-line therapy (after hedgehog inhibitors).
DOI: 10.1111/ddg.15566
Authors: Berenice M. Lang, Panagiotis Balermpas, Andrea Bauer, Andreas Blum, Thomas Dirschka, Markus Follmann, Jorge Frank, Bernhard Frerich, Klaus Fritz, Axel Hauschild, Ludwig M. Heindl, Hans‐Peter Howaldt, Stephan Ihrler, Vinodh Kakkassery, Bernhard Klumpp, Albrecht Krause‐Bergmann, Christoph Löser, Markus Meissner, Michael M. Sachse, Max Schlaak, Michael P. Schön, Lutz Tischendorf, Michael Tronnier, Dirk Vordermark, Julia Welzel, Michael Weichenthal, Susanne Wiegand, Roland Kaufmann, Stephan Grabbe
Institutions: University Medical Center of the Johannes Gutenberg University Mainz, University Hospital Zurich, University Hospital Carl Gustav Carus, Technische Universität Dresden, Klinikum Konstanz, Witten/Herdecke University, CentroDerm, German Cancer Society, Universitätsmedizin Göttingen, University of Göttingen, Universitätsmedizin Rostock, University Hospital Schleswig-Holstein, University of Cologne, University Hospital Cologne, Justus-Liebig-Universität Gießen, Klinikum Chemnitz, Rems-Murr-Klinikum, Universitätsklinikum Tübingen, University of Tübingen, Klinikum Ludwigshafen, Klinikum Bremerhaven-Reinkenheide, Humboldt-Universität zu Berlin, Freie Universität Berlin, Charité - Universitätsmedizin Berlin, Helios Kliniken, Martin Luther University Halle-Wittenberg, University of Augsburg, University Hospital Augsburg, University Hospital Leipzig, Leipzig University, Goethe University Frankfurt, University Hospital Frankfurt
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,270
OpenAlex ID: W4404697191